1.
Trends Parasitol
; 40(5): 362-366, 2024 May.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38582683
RESUMEN
The Equatorial Guinea Malaria Vaccine Initiative (EGMVI) highlights how long-term African government and international energy industry investment, plus novel partnerships, can enable clinical development of vaccines in Africa, for Africa. We review achievements and challenges of this pioneering, award-winning, public-private partnership which offers a model for future Africa-centric clinical research and development (R&D).